revenue increased by 19% to hk$9,085 million
strong underlying momentum and good profitability
(16 july, 2021 – hong kong) vinda international holdings limited (“vinda”, stock code: 3331) announced today its interim results for the six months ended 30 june 2021(the “h1 2021”).
h1 2021 results highlights：
• total revenue increased by 19.0% to hk$9,085 million
− continued to gain market share and strengthen leading position in mainland china tissue market
− e-commerce business grew by 26.0%¹
− feminine care business in mainland china delivered prominent sales data
• gross profit increased by 15.4% to hk$3,394 million; net profit increased by 6.0% to hk$967 million
• an interim dividend of 10.0 hk cents per share
• net gearing ratio² was 36.4%
ms. karen li, chief executive officer of vinda said, “in h1 2021, the progress in the pandemic control varied in the countries and regions where our business covered. despite the volatile business environment, with our clear strategic positioning and continuous optimisation of product portfolio, the group had delivered good profitability and showed resilience in maintaining business growth.”
ms. li concluded, “looking ahead, as the global pandemic has shown signs of abating, it is expected that economic recovery will continue to gain momentum in the second half of 2021. vinda will stay focus on product innovation and strive to stand out from the peers by optimising our product mix to enhance our brand competitiveness and profit margin.”
- end -
remarks: 1. at constant exchange rate
2. net gearing ratio: net debt divided by total shareholders’ equity